AI-powered and patient-inspired startup Healx secures $56 million for Series B
Healx, a startup that uses artificial intelligence to quickly identify and develop treatments for rare diseases, raises a $56 million Series B to support its clinical trials and launch of its global Rare Treatment Accelerator program.